NutriBand Inc.(NTRB)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,841 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
NTRB Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for NutriBand Inc. (NTRB), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NTRB at 16.3/100 on a 32-signal composite quality model, placing it at rank #2,841 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), NutriBand Inc. reports quarterly revenue of $437.5K, net income of $-880.6K. Top institutional holders of NTRB by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, CITADEL ADVISORS, based on the most recent SEC filings. NTRB trades on the Nasdaq exchange and files with the SEC under CIK 1676047. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NTRB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NutriBand Inc. directly from SEC EDGAR. NutriBand Inc.'s 13F Pro composite quality score has ranged between 10 and 16 since 2026, currently 16.3 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.
Revenue
Q2 2026
$437.5K
Net Income
Q2 2026
$-880.6K
ROIC
Q2 2026
-66.9%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-4.8% YoYNet Income
+21.5% YoYOperating Income
+19.1% YoYEPS (Diluted)
-160.6% YoYTotal Assets
+1.0% YoYTotal Debt
Op. Cash Flow
-11.0% YoYFree Cash Flow
-8.9% YoY| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $2.0M -4.8% | $2.1M +2.6% | $2.1M +0.3% | $2.1M +46.2% | $1.4M +50.7% | $943.7K |
| Net Income | $-8.2M +21.5% | $-10.5M -91.1% | $-5.5M -22.3% | $-4.5M +27.4% | $-6.2M -110.6% | $-2.9M |
| Operating Income | $-8.3M +19.1% | $-10.3M -111.1% | $-4.9M -8.9% | $-4.5M +26.8% | $-6.1M -135.4% | $-2.6M |
| EPS (Diluted) | $-2.58 -160.6% | $-0.99 -43.5% | $-0.69 -30.2% | $-0.53 +33.8% | $-0.80 | — |
| Total Assets | $7.5M +1.0% | $7.5M -0.6% | $7.5M -20.5% | $9.5M -25.8% | $12.7M +28.3% | $9.9M |
| Total Debt | — | — | $2.0M | — | — | — |
| Operating Cash Flow | $-5.1M -11.0% | $-4.6M -31.2% | $-3.5M -18.1% | $-3.0M -6.3% | $-2.8M -845.7% | $-297.1K |
| Free Cash Flow | $-5.1M -8.9% | $-4.7M -31.8% | $-3.6M -16.7% | $-3.1M -6.1% | $-2.9M | — |
Get alerted when NTRB's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for NutriBand Inc. including:
Top Institutional Holders of NTRB
VANGUARD CAPITAL MANAGEMENT LLC
$558.0K174,927 shGEODE CAPITAL MANAGEMENT, LLC
$199.4K62,494 shCITADEL ADVISORS LLC
$83.4K83,353 shVANGUARD FIDUCIARY TRUST CO
$80.1K25,111 shSTATE STREET CORP
$79.6K24,966 shClear Street Group Inc.
$61.6K61,630 shCITADEL ADVISORS LLC
$60.6K18,996 shEmpery Asset Management, LP
$40.2K40,218 shNORTHERN TRUST CORP
$36.9K11,570 shHaven Private, LLC
$36.3K11,366 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $558.0K | 174,927 |
| GEODE CAPITAL MANAGEMENT, LLC | $199.4K | 62,494 |
| CITADEL ADVISORS LLC | $83.4K | 83,353 |
| VANGUARD FIDUCIARY TRUST CO | $80.1K | 25,111 |
| STATE STREET CORP | $79.6K | 24,966 |
| Clear Street Group Inc. | $61.6K | 61,630 |
| CITADEL ADVISORS LLC | $60.6K | 18,996 |
| Empery Asset Management, LP | $40.2K | 40,218 |
| NORTHERN TRUST CORP | $36.9K | 11,570 |
| Haven Private, LLC | $36.3K | 11,366 |
More Healthcare Companies
View all Healthcare →Put NTRB on your watchlist
Track score changes the day NutriBand Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NTRB a good stock to buy?
13F Pro's AI-powered analysis of NutriBand Inc. (NTRB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NTRB are available on the NTRB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NTRB is classified as a small company.
Which hedge funds own NTRB?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NTRB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NutriBand Inc.'s investment landscape.